Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 1 1

Status

Terminated 1Enrolling by invitation 1Completed 1

Sponsor Class

OTHER 2OTHER_GOV 1

Study Type

Interventional 3

Sponsor

Cancer Type

Other 2

Conditions

Breast Neoplasms 11Obesity 4Sarcopenia 3Polycystic Ovary Syndrome 3Neoplasms 3Melanoma 3Prostatic Neoplasms 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Malnutrition 2Lymphoma, Follicular 2Colorectal Neoplasms 2Breast Carcinoma In Situ 2Wound Infection 1Weight Loss 1Urinary Bladder Neoplasms 1Surgical Wound Infection 1Stomach Neoplasms 1Smoldering Multiple Myeloma 1Skin Neoplasms 1Psoriasis 1Precancerous Conditions 1Postoperative Complications 1Polyps 1Phagocyte Bactericidal Dysfunction 1Pain 1Paget's Disease, Mammary 1Overweight 1Osteoarthritis 1Olfaction Disorders 1Non-alcoholic Fatty Liver Disease 1

Interventions

Metformin 152Clomiphene 52Letrozole 41Inositol 35Folic Acid 18Progesterone 17Exercise 17Ethinyl Estradiol 13Estradiol 13Chorionic Gonadotropin 13Caloric Restriction 13drospirenone and ethinyl estradiol combination 12Contraceptives, Oral 12cetrorelix 11Pioglitazone 10High-Intensity Interval Training 10Cholecalciferol 10Triptorelin Pamoate 9Tablets 9Spironolactone 9Menotropins 8Diet 8Vitamin D 7Thioctic Acid 7Surveys and Questionnaires 7Liraglutide 7Gonadotropins 7Acupuncture Therapy 7follitropin alfa 6drospirenone 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Polycystic Ovary Syndrome × Docosahexaenoic Acids × Clear all
NCT07036952 2025-07-24

Effect of Omega-3 Supplementation as Add on Therapy on Metabolic Syndrome in Women With Polycystic Ovary Syndrome.

Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh

Phase NA Enrolling by invitation
68 enrolled

Polycystic Ovary Syndrome

NCT02521753 2025-04-01

OMgObPCOS

Coordinación de Investigación en Salud, Mexico

Phase NA Terminated
123 enrolled
Other

Obesity, Polycystic Ovary Syndrome

NCT04116203 2025-02-28

PCOS

University of Alberta

Phase 1 Completed
52 enrolled
Other

Cardiovascular Diseases, Diabetes Mellitus, Obesity, Polycystic Ovary Syndrome, Lipid Metabolism Disorders

Data powered by HemOnc (CC BY 4.0) Colophon âš¡